Skip to main content
Erschienen in: Gastro-News 5/2023

16.10.2023 | Leberzirrhose | Fortbildung

Hepatologie - Teil 5 Patienten am Lebensende

Palliative Versorgung bei fortgeschrittenen Lebererkrankungen

verfasst von: Prof. Dr. med. Claus Niederau

Erschienen in: Gastro-News | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Auszug

Patienten mit schweren Lebererkrankungen benötigen oft eine palliative und hospizliche Betreuung, da sie in der Regel viele schwerwiegende Beschwerden, eine schlechte Lebensqualität und eine hohe Sterblichkeit haben. Dieser Artikel analysiert zu diesem Thema aktuelle Originalarbeiten, Reviews und Leitlinien - insbesondere aus den letzten fünf Jahren. …
Literatur
1.
Zurück zum Zitat Arney J, Gray C, Walling AM et al. Two mental models of integrated care for advanced liver disease: qualitative study of multidisciplinary health professionals. BMJ Open. 2022;12:e062836 Arney J, Gray C, Walling AM et al. Two mental models of integrated care for advanced liver disease: qualitative study of multidisciplinary health professionals. BMJ Open. 2022;12:e062836
2.
Zurück zum Zitat D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-31 D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-31
3.
Zurück zum Zitat Woodland H, Hudson B, Forbes K, et al. Palliative care in liver disease: what does good look like? Frontline Gastroenterol. 2020;11:218-27 Woodland H, Hudson B, Forbes K, et al. Palliative care in liver disease: what does good look like? Frontline Gastroenterol. 2020;11:218-27
4.
Zurück zum Zitat Woodrell CD, Hansen L, Schiano TD, et al. Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults. Clin Ther. 2018;40:512-25 Woodrell CD, Hansen L, Schiano TD, et al. Palliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults. Clin Ther. 2018;40:512-25
5.
Zurück zum Zitat Kimbell B, Murray SA, Byrne H et al. Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med. 2018; 0269216318760441 Kimbell B, Murray SA, Byrne H et al. Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med. 2018; 0269216318760441
6.
Zurück zum Zitat Goldberg DS, French B, Sahota G et al. Use of population-based data to demonstrate how waitlist-based metrics overestimate geographic disparities in access to liver transplant care. Am J Transplant. 2016;16:2903-11 Goldberg DS, French B, Sahota G et al. Use of population-based data to demonstrate how waitlist-based metrics overestimate geographic disparities in access to liver transplant care. Am J Transplant. 2016;16:2903-11
7.
Zurück zum Zitat Bryce CL et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant. 2009;9:2092-101 Bryce CL et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant. 2009;9:2092-101
8.
Zurück zum Zitat Kanwal F, Hernaez R, Liu Y et al. Factors associated with access to and receipt of liver transplantation in veterans with end-stage Liver disease. JAMA Intern Med 2021;181:949 Kanwal F, Hernaez R, Liu Y et al. Factors associated with access to and receipt of liver transplantation in veterans with end-stage Liver disease. JAMA Intern Med 2021;181:949
12.
Zurück zum Zitat Karlsen TH, Sheron N, Zelber-Sagi S et al. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet. 2022;399: 61-116 Karlsen TH, Sheron N, Zelber-Sagi S et al. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet. 2022;399: 61-116
13.
Zurück zum Zitat Verma M, Tapper EB, Singal AG, Navarro V. Nonhospice palliative care within the treatment of end-stage liver disease. Hepatology. 2020;71:2149-59 Verma M, Tapper EB, Singal AG, Navarro V. Nonhospice palliative care within the treatment of end-stage liver disease. Hepatology. 2020;71:2149-59
14.
Zurück zum Zitat Tandon P, Walling A, Patton H, Taddei T. AGA clinical practice update on palliative care management in cirrhosis: expert review. Clin Gastroenterol Hepatol. 2021;19:646-56 Tandon P, Walling A, Patton H, Taddei T. AGA clinical practice update on palliative care management in cirrhosis: expert review. Clin Gastroenterol Hepatol. 2021;19:646-56
15.
Zurück zum Zitat Verma M, Bakitas MA. Creating effective models for delivering palliative care in advanced liver disease. Curr Hepatol Rep. 2021;20:43-53 Verma M, Bakitas MA. Creating effective models for delivering palliative care in advanced liver disease. Curr Hepatol Rep. 2021;20:43-53
16.
Zurück zum Zitat Rogal SS, Hansen L, Patel A, et al. AASLD practice guidance: palliative care and symptom-based management in decompensated cirrhosis. Hepatology. 2022;76:819-53 Rogal SS, Hansen L, Patel A, et al. AASLD practice guidance: palliative care and symptom-based management in decompensated cirrhosis. Hepatology. 2022;76:819-53
17.
Zurück zum Zitat Baumann AJ, Wheeler DS, James M et al. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manage. 2015;50:882-6 Baumann AJ, Wheeler DS, James M et al. Benefit of early palliative care intervention in end-stage liver disease patients awaiting liver transplantation. J Pain Symptom Manage. 2015;50:882-6
18.
Zurück zum Zitat Kimbell B, Murray SA, Byrne H et al. Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med. 2018; 0269216318760441 Kimbell B, Murray SA, Byrne H et al. Palliative care for people with advanced liver disease: a feasibility trial of a supportive care liver nurse specialist. Palliat Med. 2018; 0269216318760441
20.
Zurück zum Zitat Radbruch L et al. Standards und Richtlinien für Hospiz- und Palliativversorgung in Europa: Teil 1. Weißbuch zu Empfehlungen der Europäischen Gesellschaft für Palliative Care (EACP) Z Palliativmed. 2011;12:216-27 Radbruch L et al. Standards und Richtlinien für Hospiz- und Palliativversorgung in Europa: Teil 1. Weißbuch zu Empfehlungen der Europäischen Gesellschaft für Palliative Care (EACP) Z Palliativmed. 2011;12:216-27
21.
Zurück zum Zitat Verma M, Kalman R, Horrow J et al. Feasibility of a Palliative Care Intervention within Routine Care of Hepatocellular Carcinoma: A Pilot Randomized Controlled Trial. J Palliat Med. 2023;26:334-41 Verma M, Kalman R, Horrow J et al. Feasibility of a Palliative Care Intervention within Routine Care of Hepatocellular Carcinoma: A Pilot Randomized Controlled Trial. J Palliat Med. 2023;26:334-41
22.
Zurück zum Zitat Kieffer SF, Tanaka T, Ogilvie AC et al. Palliative Care and End-of-Life Outcomes in Patients Considered for Liver Transplantation: A Single-Center Experience in the US Midwest. Am J Hosp Palliat Care. 2022:10499091221142841 Kieffer SF, Tanaka T, Ogilvie AC et al. Palliative Care and End-of-Life Outcomes in Patients Considered for Liver Transplantation: A Single-Center Experience in the US Midwest. Am J Hosp Palliat Care. 2022:10499091221142841
23.
Zurück zum Zitat Ufere NN, Robinson B, Donlan J et al. Pilot Randomized Controlled Trial of an Advance Care Planning Video Decision Tool for Patients With Advanced Liver Disease. Clin Gastroenterol Hepatol. 2022;20:2287-95 Ufere NN, Robinson B, Donlan J et al. Pilot Randomized Controlled Trial of an Advance Care Planning Video Decision Tool for Patients With Advanced Liver Disease. Clin Gastroenterol Hepatol. 2022;20:2287-95
24.
Zurück zum Zitat Rosenstengle C, Kripalani S, Rahimi RS. Hepatic encephalopathy and strategies to prevent readmission from inadequate transitions of care. J Hosp Med. 2022;17:17-23 Rosenstengle C, Kripalani S, Rahimi RS. Hepatic encephalopathy and strategies to prevent readmission from inadequate transitions of care. J Hosp Med. 2022;17:17-23
25.
Zurück zum Zitat Johnson AW, Byriel B, Rubeck J et al. Standardized Criteria Increases Palliative Care Consultation Utilization in Patients With End-Stage Liver Disease: A Pilot Study. Am J Hosp Palliat Care. 2022:10499091221127984 Johnson AW, Byriel B, Rubeck J et al. Standardized Criteria Increases Palliative Care Consultation Utilization in Patients With End-Stage Liver Disease: A Pilot Study. Am J Hosp Palliat Care. 2022:10499091221127984
26.
Zurück zum Zitat National End of Life Care Intelligence Network. Deaths from liver disease: implications for end of life care in England. https://​www.​ias.​rg.​uk/​uploads/​pdf/​News%20stories/nhs-endoflife-liverdisease-report.pdf National End of Life Care Intelligence Network. Deaths from liver disease: implications for end of life care in England. https://​www.​ias.​rg.​uk/​uploads/​pdf/​News%20stories/nhs-endoflife-liverdisease-report.pdf
27.
Zurück zum Zitat Cross SH, Ely EW, Kavalieratos D et al. Place of Death for Individuals With Chronic Lung Disease. Chest. 2020;158:670-80 Cross SH, Ely EW, Kavalieratos D et al. Place of Death for Individuals With Chronic Lung Disease. Chest. 2020;158:670-80
28.
Zurück zum Zitat Verma S, Verne J, Ufere NN. Palliative care in advanced liver disease: time for action. Lancet Gastroenterol Hepatol 2023;8:106-8 Verma S, Verne J, Ufere NN. Palliative care in advanced liver disease: time for action. Lancet Gastroenterol Hepatol 2023;8:106-8
29.
Zurück zum Zitat Jordan RI, El Mokhallalati Y, Corless L, Bennett M. Quality of end-of-life care with non-malignant liver disease: Analysis of the VOICES National Survey of Bereaved People. Liver Int. 2023;43:308-16 Jordan RI, El Mokhallalati Y, Corless L, Bennett M. Quality of end-of-life care with non-malignant liver disease: Analysis of the VOICES National Survey of Bereaved People. Liver Int. 2023;43:308-16
30.
Zurück zum Zitat Ufere NN, Donlan J, Waldman L et al. Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease. Clin Gastroenterol Hepatol. 2019;17:2592-99 Ufere NN, Donlan J, Waldman L et al. Barriers to Use of Palliative Care and Advance Care Planning Discussions for Patients With End-Stage Liver Disease. Clin Gastroenterol Hepatol. 2019;17:2592-99
31.
Zurück zum Zitat Williams R, Ashton K, Aspinall R et al. Implementation of the Lancet Standing Commission on Liver Disease in the UK. Lancet. 2015;86:2098-111 Williams R, Ashton K, Aspinall R et al. Implementation of the Lancet Standing Commission on Liver Disease in the UK. Lancet. 2015;86:2098-111
32.
Zurück zum Zitat Low JTS, Rohde G, Pittordou K et al. Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals. J Hepatol. 2018;69:1260-73 Low JTS, Rohde G, Pittordou K et al. Supportive and palliative care in people with cirrhosis: International systematic review of the perspective of patients, family members and health professionals. J Hepatol. 2018;69:1260-73
33.
Zurück zum Zitat Mohy-Ud-Din N, Syed A, Strahotin C, Babich M. Predictors and Outcomes of Palliative Care Consultations for Patients With Liver Disease: Results of a Cohort Study of 75 Million Medical Records. Am J Hosp Palliat Care. 2023:10499091231152229 Mohy-Ud-Din N, Syed A, Strahotin C, Babich M. Predictors and Outcomes of Palliative Care Consultations for Patients With Liver Disease: Results of a Cohort Study of 75 Million Medical Records. Am J Hosp Palliat Care. 2023:10499091231152229
34.
Zurück zum Zitat Gupta K, Hans B, Khan A et al. A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States. World J Hepatol. 2022;14:1817-29 Gupta K, Hans B, Khan A et al. A retrospective study on use of palliative care for patients with alcohol related end stage liver disease in United States. World J Hepatol. 2022;14:1817-29
35.
Zurück zum Zitat Orman ES, Yousef A, Xu C et al. Palliative Care, Patient-Reported Measures, and Outcomes in Hospitalized Patients With Cirrhosis. J Pain Symptom Manage. 2022;63:953-61 Orman ES, Yousef A, Xu C et al. Palliative Care, Patient-Reported Measures, and Outcomes in Hospitalized Patients With Cirrhosis. J Pain Symptom Manage. 2022;63:953-61
36.
Zurück zum Zitat Patel A, Walling AM, Ricks-Oddie J et al. Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life. Clin Gastroenterol Hepatol. 2017;15:1612-19 Patel A, Walling AM, Ricks-Oddie J et al. Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life. Clin Gastroenterol Hepatol. 2017;15:1612-19
37.
Zurück zum Zitat Wright M, Woodland H, Hudson B. Symptom control in advanced chronic liver disease: integrating anticipatory palliative and supportive care. Frontline Gastroenterol. 2022;13:e109-15 Wright M, Woodland H, Hudson B. Symptom control in advanced chronic liver disease: integrating anticipatory palliative and supportive care. Frontline Gastroenterol. 2022;13:e109-15
38.
Zurück zum Zitat Berry P, Kotha S. Improving end of life care in liver disease. J Hepatol. 2022;76:1225-6 Berry P, Kotha S. Improving end of life care in liver disease. J Hepatol. 2022;76:1225-6
39.
Zurück zum Zitat Thandassery RB, Sharma S, Syed M, Perisetti A. A global multicenter propensity-matched analysis of mortality risk and palliative care referral due to cirrhosis in hospitalized patients with COVID-19. J Clin Transl Res. 2022;8:414-20 Thandassery RB, Sharma S, Syed M, Perisetti A. A global multicenter propensity-matched analysis of mortality risk and palliative care referral due to cirrhosis in hospitalized patients with COVID-19. J Clin Transl Res. 2022;8:414-20
40.
Zurück zum Zitat Tombazzi CR, Howe CF, Slaughter JC, Obstein KL. Rate of and Factors Associated with Palliative Care Referral among Patients Declined for Liver Transplantation. J Palliat Med. 2022;25:1404-8 Tombazzi CR, Howe CF, Slaughter JC, Obstein KL. Rate of and Factors Associated with Palliative Care Referral among Patients Declined for Liver Transplantation. J Palliat Med. 2022;25:1404-8
41.
Zurück zum Zitat Whitsett MP, Ufere NN, Patel A et al. Palliative care experience and perceived gaps in training among transplant hepatology fellows: A national survey. Hepatol Commun. 2022;6:1680-8 Whitsett MP, Ufere NN, Patel A et al. Palliative care experience and perceived gaps in training among transplant hepatology fellows: A national survey. Hepatol Commun. 2022;6:1680-8
42.
Zurück zum Zitat Serper M, Parikh ND, Thiele G et al. Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022;76:251-74 Serper M, Parikh ND, Thiele G et al. Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022;76:251-74
43.
Zurück zum Zitat Rakoski MO, Volk ML. Palliative care and end-stage liver disease: a critical review of current knowledge. Curr Opin Gastroenterol. 2019;35:155-60 Rakoski MO, Volk ML. Palliative care and end-stage liver disease: a critical review of current knowledge. Curr Opin Gastroenterol. 2019;35:155-60
44.
Zurück zum Zitat Ozdogan OC. Palliative care in cirrhotic patients: Brief summary of recent AASLD guidance. Hepatol Forum. 2022;3:100-2 Ozdogan OC. Palliative care in cirrhotic patients: Brief summary of recent AASLD guidance. Hepatol Forum. 2022;3:100-2
45.
Zurück zum Zitat Niederau C. Betreuung von Zirrhosepatienten im Endstadium. Gastro-News. 2919;6:18 Niederau C. Betreuung von Zirrhosepatienten im Endstadium. Gastro-News. 2919;6:18
46.
Zurück zum Zitat Kimbell B, Boyd K, Kendall M et al. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open. 2015;5:e009241 Kimbell B, Boyd K, Kendall M et al. Managing uncertainty in advanced liver disease: a qualitative, multiperspective, serial interview study. BMJ Open. 2015;5:e009241
47.
Zurück zum Zitat Low J, Davis S, Vickerstaff V et al. Advanced chronic liver disease in the last year of life: a mixed methods study to understand how care in a specialist liver unit could be improved. BMJ Open. 2017;7:e016887 Low J, Davis S, Vickerstaff V et al. Advanced chronic liver disease in the last year of life: a mixed methods study to understand how care in a specialist liver unit could be improved. BMJ Open. 2017;7:e016887
48.
Zurück zum Zitat Low point JTS, Rohde G, Pittordou K et al. Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals. J Hepatol. 2018;69:1260-7 Low point JTS, Rohde G, Pittordou K et al. Supportive and palliative care in people with cirrhosis: international systematic review of the perspective of patients, family members and health professionals. J Hepatol. 2018;69:1260-7
49.
Zurück zum Zitat Drysdale K, Rance J, Cama E et al. What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review. Health Soc Care Community. 2022;30:e3775-88 Drysdale K, Rance J, Cama E et al. What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review. Health Soc Care Community. 2022;30:e3775-88
50.
Zurück zum Zitat Cross SH, Ely EW, Kavalieratos D et al. Place of death for individuals with chronic lung disease: trends and associated factors from 2003 to 2017 in the United States. Chest. 2020;158:670-80 Cross SH, Ely EW, Kavalieratos D et al. Place of death for individuals with chronic lung disease: trends and associated factors from 2003 to 2017 in the United States. Chest. 2020;158:670-80
51.
Zurück zum Zitat Aithal GP, Palaniyappan N, China L et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70:9-29 Aithal GP, Palaniyappan N, China L et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70:9-29
52.
Zurück zum Zitat Standing H, Jarvis H, Orr J et al. How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners' perceptions and experiences. BMJ Open. 2017;7:e017106 Standing H, Jarvis H, Orr J et al. How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners' perceptions and experiences. BMJ Open. 2017;7:e017106
Metadaten
Titel
Hepatologie - Teil 5 Patienten am Lebensende
Palliative Versorgung bei fortgeschrittenen Lebererkrankungen
verfasst von
Prof. Dr. med. Claus Niederau
Publikationsdatum
16.10.2023
Verlag
Springer Medizin
Erschienen in
Gastro-News / Ausgabe 5/2023
Print ISSN: 1869-1005
Elektronische ISSN: 2520-8667
DOI
https://doi.org/10.1007/s15036-023-3286-z

Weitere Artikel der Ausgabe 5/2023

Gastro-News 5/2023 Zur Ausgabe

Passend zum Thema

ANZEIGE

Synergien nutzen gegen Tumore

Lungen- und Magentumore können dank Immuntherapien deutlich besser behandelt werden. Dennoch kommt es trotzdem weiterhin häufig zum Krankheitsprogress. Welche Therapieoptionen sich in der Zweitlinie am besten eignen, haben wir für Sie zusammengefasst.

ANZEIGE

Darmkrebsreihenuntersuchungen zeigen EU-weit Erfolge

In Europa haben viele Länder dem Darmkrebs mit Hilfe von Früherkennungsprogrammen den Kampf angesagt. Es gibt einen deutlichen Zusammenhang zwischen Inzidenz und Mortalität von Darmkrebs und der Zeitspanne seit Einführung von Reihenuntersuchungen.

ANZEIGE

GI-Tumore und die Rolle von Angiogenesehemmern

Content Hub

Entdecken Sie mit praxisrelevanten Patientenfällen, kompakten Studieninhalten, informativen Experteninterviews und weiteren spannenden Inhalten, wie Sie den vielseitigen Herausforderungen bei GI-Tumoren begegnen können. Hier erfahren Sie mehr! PP-RB-DE-2009

Passend zum Thema

DKK 2024
21. - 24. Februar 2024 | Berlin

Kongressdossier zum Deutschen Krebskongress 2024

Auf dieser Seite werden wir Sie mit tagesaktuellen Berichten vom Deutschen Krebskongress auf dem Laufenden halten. Vor dem Start des Kongresses finden Sie hier zudem Ausblicke auf spannende Themen. Expertinnen und Experten erzählen, auf welche DKK-Sessions sie sich besonders freuen.

In Kooperation mit:
Deutsche Krebsgesellschaft e. V. und Stiftung Deutsche Krebshilfe